Bill would give Medicare authority to issue competitive licensing to generics
Yesterday, Rep. Lloyd Doggett (D-TX) and Sen. Sherrod Brown (D-OH) introduced identical bills that would address the prescription drug affordability crisis. The Medicare Negotiation and Competitive Licensing Act would authorize the Secretary of Health and Human Services (HHS) to negotiate drug prices, and if drug companies refuse to negotiate in good faith, it would enable the Secretary to issue a competitive license to another company to produce the medication as a generic.
Rep. Doggett, a member of the Ways and Means Health Subcommittee, introduced his bill in the House joined by Reps. Peter Welch (D-VT) and Elijah Cummings (D-MD), along with more than 100 Democratic cosponsors. Several advocacy groups, such as Public Citizen, Families USA, and the Progressive Change Campaign Committee, support the measure. In the Senate, Brown is the lead sponsor of the bill; original cosponsors are Amy Klobuchar (D-MN) and Tammy Baldwin (D-WI).
The Ways and Means Committee is set to hold a hearing on prescription drug prices next week. We will keep you updated.